Design and synthesis of indolamine dioxygenase (IDO) for the treatment of cancer

Project: Research

Research Output

  • 7 Poster
  • 4 Article
  • 3 Literature review
  • 1 Conference contribution
Filter
Literature review
2013

Indoleamine 2,3-dioxygenase inhibitors: a patent review (2008-2012)

Dolušić, E. & Frédérick, R., 1 Oct 2013, In : Expert opinion on therapeutic targets. 23, 10, p. 1367-1381 15 p.

Research output: Contribution to journalLiterature review

2010

Discovery and optimization of indole-pyridinyl-ethanones as novel inhibitors of indoleamine-2-3 dioxygenase (IDO), a promising target for anti-cancer immunotherapy.

Frédérick, R., Blanc, S., Larrieu, P., Moineaux, L., Colette, D., Fraser, G., Stroobant, V., Pilotte, L., Colaux, D., Wouters, J., Masereel, B., Van den Eynde, B. & Dolušić, E., 2010, In : Drugs of the future. 35, suppl A, p. 181-182

Research output: Contribution to journalLiterature review

Structural and enzymatic study of tryptophan 2,3-dioxgenase (TDO), a potential target in anticancer immunotherapy.

Moineaux, L., Charlier, C., Dolušić, E., Larrieu, P., Pilotte, L., Colaux, D., Stroobant, V., Galleni, M., Masereel, B., Van den Eynde, B., Wouters, J. & Frédérick, R., 2010, In : Drugs of the future. 35, suppl A, p. 189

Research output: Contribution to journalLiterature review